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ATS/ERS evaluation of ILD’s has recently considered NSIP as a single entity and it has historically been
considered a provisional diagnosis. As more cases are reviewed, pathologic characteristics may become
more precise with less overlap and help in diagnosis of complex cases.
Here, we present a series of cases of HP and NSIP recently admitted to Masih Daneshvari Hospital with
hope to characterize them better and eventually have less ambiguity about nature of NSIP.
 2011 Published by Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
Researchers have presented article on differences between NSIP
and UIP (Unspeciﬁc Interstitial Pneumonia) in this Journal’s
number 3 issue 4 of year 2008 that were contributed probably to
more severe inﬂammatory condition in NSIP compared to UIP. In
this article also, more signiﬁcant difference in HRCT ﬁndings
between NSIP and UIP were discussedwhich can differentiate these
two cases from each other. Review by ATS/ERS on interstitial lung
diseases, distinguishes NSIP and HP as separate entities. As more
cases are reviewed, pathologic characteristics may become more
precise with less overlap and help in diagnosis of complex cases.1e3
Case review of three new patients showed that there can be
overlap between the two ILD’s, HP and NSIP such that pathologic
differentiation between the cases despite new methods is difﬁcult
which can be due to overlap between the two or new terminology
in the ﬁeld of ILD studies.
2. Case 1
The ﬁrst patient is a 32-year-old lady from out of Tehran who
presents to this center with increasing dyspnea for 2 months and
ﬁndings consistent with interstitial ﬁbrosis in lung apices on CT
scan. She has been diagnosed with possible sarcoidosis or chronic
HP a year prior to admission based on lack of granuloma found in
lung biopsy and was referred for diagnostic evaluation. Patient
noted that in the last 10 days dyspnea has increased and she was.
ess under CC BY-NC-ND license.now considered FC IV. She notes pulmonary symptoms began 3
years ago with dry coughs and increasing dyspnea such that she is
currently oxygen dependent. Medications were ﬂuoxetide, atro-
vent, salmeterol, Azaram 50 mg bid, ranitidine and prednisolone
25 mg qd. She denies any drug allergies. She has family history of
asthma in uncle. On physical exam vital signs were BP¼ 100/60,
PR¼ 98, RR¼ 30 and oral T¼ 36.7 C. She was in no acute distress.
She had no head and neck jugular venous distension or lymph-
adenopathy. Cardiac exam was normal with heart sounds S1, S2
heard and nomurmurs, rubs or gallops present. Lung exam showed
ronchi at both bases. Abdomen was soft, nontender with no orga-
nomegally. No clubbing, cyanosis or edema was noted. Neurology
exam was normal.
Spiral Aorta Thoracic CT showed bilateral symmetrical intersti-
tial ﬁbrosis more prominent in upper lobes with posterior retracted
main stem bronchi in favor with sarcoidosis.
Pathology slides from a year ago from Mashad were reviewed
which were compatible with NSIP and evidence of acute exacer-
bation (proliferative phase). Presence of individual interstitial giant
cells and focal bronchiolizationwas noted with recommendation to
consider HP. Review of microscopy included lung parenchymawith
temporally uniform interstitial inﬂammation and mild scattered
ﬁbrosis. Predominate inﬁltrative cells were small lymphocytes and
occasional plasma cells. Lymphocyte aggregations were noted with
accentuation around respiratory bronchioles. There was marked
alveolar pneumocyte hyperplasia, ﬁbroblastic foci, and pleural
inﬁltration with chronic inﬂammatory cells.
Spirometry showed FEV1 17%, FVC 15% and FEF25 75 23%
predicted.
Sputum smear for BK was negative times three.
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and CBC. ESR was 28 mm/h and RF was positive. Other rheuma-
tology titers were ANA (IF) negative, anti-ds-DNA 0.1 mg/dl, anti-
ccp Ab 1.4 IU/ml, Scl 70 3.7, anti-centromere Ab 1.4 IU/ml, Jo Ab
7.6 IU/L and within the normal range. Patient was anti-HIV (ELISA)
negative. ACE level was normal.
Patient was admitted with continuation of current medications.
In this patient granulomas were not found on pathology and
presence of individual interstitial giant cells and focal bronchioli-
zation was noted with recommendation to consider HP. Diagnosis
to be considered is HP maybe due to history of mycoplasma
pneumonia with dry coughs.3. Case 2
The second case is a 30-year-old male farmer with history of
exposure to toxins andwell drilling in the oil industrywho presents
with progressive dyspnea and right-sided pleuritic chest pain for
the past year. Patient’s functional class has varied between I and IV.
He notes worsening of symptoms in the sitting position. He has had
weakness and fevers with chills in the afternoons with nightly
sweats for the past year. He has been hospitalized with diagnosis of
pneumonia, but never fully recovered after discharge and
continued to have dry coughs which were worse on exertion. He
has had decreased appetite with weight loss of 15 kg in the past 8
months. He denies cough or sputum and has been referred by
specialist from the city of Ahvaz where he was worked up with
chest X-ray showing interstitial inﬁltrate in base of two lungs,
restrictive spirometry, normal bronchoscopy and smear for BK. He
has continued to have exert ional dyspnea and as a result was
referred to this center. Medications on admission were predniso-
lone started at 60 mg/d and tapered over 6 months to the current
dose of 5 mg/d, theophyline 200 mg qd and omeprazole. He is
nonsmoker and does not drink alcohol or abuse substance. He has
history of pancreatic cancer in his father. On physical exam vital
signs are BP¼ 100/60, PR¼ 100, RR¼ 16 and oral T¼ 37.2 C. The
patient was a young man alert and oriented providing history. He
had no jugular venous distension or head and neck lympadenop-
athy. Cardiac exam was normal with heart sounds S1 and S2
present with no murmurs, rubs or gallops auscultated. Lung exam
showed decreased breath sounds in the right lung base and hyper
resonance on percussion. Abdominal exam showed epigastric
tenderness with no organomegally. There was no clubbing,
cyanosis or edema noted. Neurology exam was normal.
HRCT of lung showed uniform ground glass opacities in
dependent part of lower lung zone, mosaic pattern of attenuation in
the rest of lung parenchyma and reported as nonspeciﬁc consistent
with BOOP, PCP or early NSIP.
Bronchoscopy was done which showed bronchial narrowing
due to external compression in lingula.
Bronchoalveolar lavage showed neutrophilia (17%) with 256
lymphocyte count and CD4/CD8 ratio of 3.8 and was negative for
malignancy.
Results of open lung biopsy were reported as consistent with
NSIP pattern either idiopathic or secondary to another process.
Considering occupation of farming, it was recommended that
chronic HP be investigated.
Microscopy showed lung tissue with mild alveolar architectural
distortion due to diffuse interstitial edema, chronic inﬂammatory
cell inﬁltration mostly small lymphocytes and some eosinophils
and in some areas also interstitial ﬁbrosis. Also noted were diffuse
pneumocyte type II hyperplasia, scattered Masson bodies and
patchy DIP like reaction. No granulomas, honeycomb changes or
smooth muscle hyperplasia were seen.Laboratory tests showed normal renal functions with leukocy-
tosis (12.7 cell/MicroL) and neutrophilia on CBC. ESR was 41 mm/h,
CRP was positive and RF was negative. Other tests were CANCA
(ELISA) 4.0 U/ml, PANCA (ELISA) 0.8 U/ml, C3 1.47 g/l (Nephelo-
metric), C4 0.36 g/l, ANA (IF) negative, anti-ds DNA 0.61whichwere
within normal limits. Anti-HIV (ELISA) was nonreactive.
Sputum smear for BK and fungi was negative.
Patient was hospitalized with current medications and under-
went bronchoscopy with TBLB after which he developed pneu-
mothorax with need for chest tube insertion. Inadequate biopsy
specimen led him to have open lung biopsy. Hospital course was
complicated with wound infection and treated with course of
antibiotics ceftazidime. Upon recovery, patient was discharged
with medications Azathioprim 50 mg/d to be increased to bid and
prednisolone 50 mg/d.
In this patient, results of open lung biopsy were reported as
consistent with NSIP pattern either idiopathic or secondary to
another process. Pathology report noted lung tissue with mild
alveolar architectural distortion due to diffuse interstitial edema,
chronic inﬂammatory cell inﬁltration mostly small lymphocytes
and some eosinophils and in some areas also interstitial ﬁbrosis.
Although, in this case neutrophilia in PBC and Masson Bodies on
pathology are consistent with HP.
Diagnosis to be considered is NSIP maybe due to paraneoplastic
process.
4. Case 3
The third patient is a 15-year-old girl who presents with
complain of fever and decreased weight of 2e3 kg during the past
month and arthralgia in the knees for the past 8 days. The patient
was hospitalized one month prior to this admission with provi-
sional diagnosis of chronic sarcoidosis with normal bronchoscopy
and BAL negative for malignancy and TBLB not diagnostic. She
denies any other past medical history, taking any medications or
having any known drug allergies. She was up-to-date on her
immunizations. She has family history of breast cancer in her
mother. On physical exam, vital signs were BP¼ 100/70, PR¼ 85,
RR¼ 20 and oral T¼ 36.9 C. The patient was in no acute distress.
Her skin was pale. No lymphadenopathy was palpated. Cardiac
exam was normal. Pulmonary exam showed crepitation in base of
left lung. Abdominal exam was normal. There was no clubbing,
cyanosis or edema or joint tenderness palpated. Neurology exam
was normal.
HRCT was consistent with cystic lesions accompanied by
thickened intralobar septae.
Paranasal CT was consistent with uniform opacity in posterior
ethmoidal cells. Echocardiography was normal.
The patient underwent open lung biopsy via anterior thora-
cotomy. Pathology report was emphysematous change with para-
septal bleb formation, unclassiﬁed interstitial lung disease
consistent with NSIP due to HP or collagen vascular disease, or
idiopathic NSIP. It was recommended that due to extensive
emphysematous change superimposed pathology on a background
childhood disease be investigated.
Biopsies from RML and RLL were taken. Microscopic examina-
tion form RML biopsy showed lung parenchyma with emphyse-
matous change, patchy interstitial thickening due to inﬂammatory
cell inﬁltration including lymphocytes, histiocytes and a few
eosinophils and mild ﬁbrosis. Also noted was paraseptal cyst
without any lining (bleb) and intraalveolar macrophages. Biopsy of
RLL showed lung parenchyma with diffuse interstitial thickening
due to inﬂammation and slight ﬁbrosis, fresh hemorrhage in alve-
olar spaces, edema ﬂuid and few cast like PAS positive material. No
granuloma or malignancy was noted.
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CD1a and S100 revealed few scattered immunoreactive cells in
interstitial space. IHC for PC was negative.
Sputum smear was negative for fungi. Laboratory tests showed
normal renal function tests with leukocytosis (15.5 cells/MicroL)
and neutrophilia (Neut 80%) on CBC as well as anemia with Hgb
9.9 g/dl, MCV 76.3 ﬂ and RDW of 17.5 and increased. ACE level was
63 IU/L. Other tests included SSA/RoIG 9.0 U/ml and SSB/LaIgG
6.0 U/mL which were within normal limits. Tests from previous
hospitalization were ESR 87 mm/h and RF negative. Also noted
from previous admission were Parvovirus B19 negative, anti-ds
DNA 0.83, CANCA 4.4 u/ml, PANCA 2.2 u/ml, ANA negative which
were within normal limits. HIV (RTPCR) and HCV antibody titers
were negative. Urinalysis was normal.
Pathology report was emphysematous change with paraseptal
bleb formation, unclassiﬁed interstitial lung disease consistent with
NSIP due to HP or collagen vascular disease, or idiopathic NSIP. It
was recommended that due to extensive emphysematous change
superimposed pathology on a background childhood disease be
investigated. Diagnosis to be considered is NSIP due to collagen
vascular disease and snifﬁng glue.Table 1
Differential diagnosis for HP.10
Differential diagnoses
Asbestosis Pneumonia, viral
Chemical worker’s lung Polymyositis
Chlamydial pneumonias Pulmonary eosinophilia
Coal worker’s pneumoconiosis Pulmonary ﬁbrosis, idiopathic
Farmer’s lung Pulmonary ﬁbrosis, interstitial
(nonidiopathic)
Goodpasture syndrome Restrictive lung disease
Metastatic cancer,
unknown primary site
Rheumatoid arthritis
Microscopic polyangiitis Sarcoidosis
Miliary tuberculosis Systemic lupus erythematosus
Mixed connective-tissue disease Wegener granulomatosis
Mycoplasma infections
Pneumonia, bacterial
Pneumonia, community-acquired5. NSIP and HP
The ability to diagnose NSIP (nonspeciﬁc interstitial pneumonia
or a form of idiopathic interstitial lung disease) and other forms of
chronic interstitial lung disease is considered signiﬁcant as it not
only agrees with different prognosis, but also may inﬂuence course
of treatment. As a result, early diagnosis of interstitial lung disease
and pulmonary referral is of signiﬁcant prognostic value for the
patient.2,4,5
Authors of this case series also recently performed a study on 61
cases, 11 NSIP and 50 UIP, where pathologic diagnosis was reviewed
and searched for noninvasive comparative diagnostic features.
Clinical symptomatology was not distinguishing. The study focuses
particularly on thin section CT scan ﬁndings with 1-mm collima-
tion. HRCT of 36 patients (60%) showed honeycombing and 24
patients (40%) bilateral ground-glass and irregular reticular pattern.
Lack of sub-pleural honeycombing was seen in UIP. Predominant
histologic features of NSIP were interstitial inﬂammation and
ﬁbrosis. Other characteristics found to be helpful diagnostically
included time interval between symptom onset and diagnosis
(based on HRCT ﬁnding, on average NSIP was diagnosed a few
months earlier than UIP), mean age and gender.3
Pathologic characteristic of NSIP is uniform thickening of alve-
olar walls with a spectrum of cellular to ﬁbrosing patterns. Recent
ATS/ERS review of 305 cases of which 193 had sufﬁcient data for
diagnosis, has suggested NSIP as a separate entity rather than
previously thought that it is more a temporary diagnosis. Exclusion
of other interstitial lung diseases being of primary concern. NSIP is
considered to have good prognosis. Additionally 66 patients were
followed up from 0.6 to 19.44 years of which 8 patients passed
away (7 from NSIP and 1 from nonrespiratory cause) and 1 patient
underwent lung transplantation. Two patients subsequently
showed Collagen Vascular Disease (scleroderma and polymyositis).
Extensive pathology review of 67 probable cases is summarized as
follows: varying amounts of interstitial inﬂammation and ﬁbrosis
uniformly appearing. Two varieties were distinguished: cellular
(16% of cases) with mild to moderate chronic inﬂammatory inter-
stitial inﬁltrate with little ﬁbrosis and ﬁbrosing (84% of cases) with
interstitial thickening by uniform ﬁbrosis of same age with pres-
ervation of alveolar architecture and various amounts of cellular
inﬂammation. Clinical presentation was breathlessness and cough
of 6e7 months, mostly women, never-smoker and in 6th decade oflife. In cases of histological similarity between NSIP and HP, clinical
history of antigen exposure guided diagnosis.6
Pulmonary drug toxicity another cause associated with NSIP is
frequently caused by cytotoxic drugs such as cyclophosphamide,
bleomycine, carmustine. NSIP has been reported with carmustine
toxicity or noncytotoxic drugs such as amiodarone. Other non-
cytotoxic drugs associated with pulmonary toxicity include nitro-
furantoin, sulfasalazine and gold salts.7
One study compared BAL ﬁndings in patients with sarcoidosis
versus HP. They noted lymphocytosis consistent with sarcoidosis
and Masson bodies have been observed in HP or extrinsic allergic
alveolitis.8
Another form of interstitial lung disease that often presents with
chronic respiratory symptoms and needs to be distinguished from
NSIP is hypersensitivity pneumonitis for antigen avoidance and
preventive measures.
Hypersensitivity pneumonitis or extrinsic allergic alveolitis is
characterized by diffuse parenchymal and airways inﬂammation
due to inhaled antigens previously sensitized to. Symptoms occur
4e8 h after exposure. Studies in England have shown that inci-
dence is 0.9 per 100,000 person years, with mean age of diagnosis
of 57, equal male to female ratio and patients less likely to be
smokers. HP is classiﬁed into acute, sub-acute or intermittent and
chronic progressive. This disease has been associated with trades
involving: farming, ventilation and water related contamination,
birds/poultry, veterinary work and animal handling, grain and ﬂour
processing, milling and construction, plastics, painting, electronics,
textile workers and others. Treatment is mainly through antigen
avoidance and prevention with corticosteroids 0.5e1 mg/kg daily.9
A list of differential diagnoses for HP is provided below (Table 1).
Clinical predictors of HP include exposure to known offending
antigen, recurrent symptomatic episodes, presence of precipitating
antibodies to offending agent, inspiratory crackles, and symptom
onset 4e8 h after exposure andweight loss. Acute HP presents with
ﬂu like symptoms that resolve in 12e24 h. Sub-acute HP is more
like chronic bronchitis and chronic disease presents as uncon-
trolled acute or sub-acute cases similar to end-stage pulmonary
ﬁbrosis. Patients are hypoxemic with exercise and even at rest.
Recommended laboratory tests have shown leukocytosis, neutro-
philia, elevated ESR, elevated quantitative immunoglobulins and
CRP.
Chest X-ray in acute HP shows micro nodular or reticular
opacities, mostly found in lower and middle lung. Sub-acute HP
shows micronodular or reticular opacities in mid to upper lung and
chronic HP shows progressive ﬁbrotic changes with loss of volume,
and signiﬁcant upper lobe emphysema.
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Pulmonary function test is restrictive with mixed obstruction in
chronic disease and increased DLCO.
Diagnostic procedures include inhalation challenge, BAL ﬁnd-
ings of >20% lymphocytosis. Lung biopsy is consistent with small
poorly formed non-caseating granulomas near respiratory or
terminal bronchioles associated with multinucleated giant cells.
Deﬁning feature of chronic HP is bridging ﬁbrosis between peri
bronchiolar and peri lobular areas.10
Pathogens include microbes, animal and plant proteins and low
molecular weight chemicals. The most common bacterial cause is
thermophilic (heat-loving) actinomycetes (gram positive ﬁlamen-
tous bacilli) that live in warm (50e60 C) and moist environment
such as in decaying vegetation. Mycobacterium avium has caused
HP in hot tub users. Fungus etiology includes Aspergillus species
observed to cause disease in corn and malt workers. Protein
etiology has been associatedwith bird keeping and chemical agents
include isocyanates found in foam, glue and spray paint. Exposure
as short as 2 years and as long as 11 years to the agent has in some
cases caused HP.
HRCT shows abnormality in 90% of patients. CT features of HP
are lobular air trapping, centrilobular ground-glass opacities and
absence of lower lobe predominance. In contrast, CT features of
NSIP are relative sub-pleural sparing, absence of air trapping and
absence of honeycombing.
Precipitating antibodies to offending antigen (usually IgG) is
found in most cases of HP but are not speciﬁc. BAL CD4/CD8 ratio is
<1 (normal being 1.8).11
In patients with ILD, connective tissue diseases (RA, Sjogren,
MCTD, etc) and underlying medical condition such as cancer (in
case of PM/DM) need to be investigated. Connective tissue disease
may present with lung involvement. Some cases of limited sclero-
derma may not have positive routine antibodies and in suspicious
cases (such as with Reynaud’s) non-commercially available tests
such as anti body to Th/To ribonucleoprotein are recommended.
Also to be considered are drug-induced and occupational diseases
(asbestosis and silicosis).1,2
Isocyanites have been shown to cause chemical penumonitis
(HP). This toxicity has been reported in car company workers, foam
production, injection molding, paint sparying and adhesive appli-
cation. It has been associated with pulmonary disease anemia
syndrome. Characteristic laboratory ﬁndings have been leukocy-
tosis in PBC and increased neutrophils in BAL in acute stages.12
Further evidence supporting possible involvement of different
pathology is gene expression signature variation between differentforms of ILD, also HP and NSIP. In a study on this topic, it was found
that HP signature included genes related to inﬂammation, T-cell
activation and immune responses. IPF involved more remodeling,
etc. Among the cases of NSIP, 2 showed IPF-like gene expression
and one HP and the remaining resembled neither and may present
idiopathic NSIP.13
As a result, when facing a pulmonary patient with chronic
symptoms and ﬁndings suggestive of interstitial lung disease,
exclusion of antigen exposure and its contribution to disease
includes important part of history taking and also attention to
underlying medical conditions particularly in cases suggestive of
NSIP. ATS/ERS evaluation of ILDs has recently considered NSIP as
a single entity and it has historically been considered a temporary
diagnosis. As more cases are reviewed, pathologic characteristics
may becomemore precisewith less overlap and help in diagnosis of
complex cases.References
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